Vandaag 13 oktober de 11e Wereld Trombosedag! CARIM & MUMC+ op locatie bij Vitala+ geriatrische revalidatiezorg in Maastricht. Inzicht in trombose en behandeling door clinici Winckers en Aarts, veel vragen, vlaai en koffie odz: “Stop de prop”. Trombosestichting Maastricht UMC+

Don't miss the upcoming @ISTH #EarlyCareer career development webinar on October 22 at 13:00 UTC on ➡️research careers outside of academia w/Amalie Carnbring Deemand, Patrick Fogarty, moderated by Dr. Julia S. Gauer bit.ly/3zdeHdW

Science! Have you read the #PEERLESS trial comparing #thrombectomy (#LBMT) with #catheter-directed #thrombolysis (#CTD) for Intermediate-risk #pulmonary #embolism (#PE)? A critical read and analysis: 🧵1/5 ahajournals.org/doi/10.1161/CI…

📢 The countdown is on! The #ISTH2025 abstract submission portal opens Nov 29. Ready to showcase your research on the global stage? Join us for an incredible Congress—submit your work and be part of the conversation driving advancements in thrombosis and hemostasis! Abstract

📣📣The ECC's latest editorial is out! Hope you enjoy reading it as much as we enjoyed writing it Interdisciplinarity within thrombosis and hemostasis: opportunities for early career professionals to find their niche -Journal of Thrombosis and Haemostasis jthjournal.org/article/S1538-…

📍New editorial from the ISTH Early Career Committee highlighting the importance of interdisciplinary collaboration and its opportunities within the thrombosis and hemostasis field. 🔖 #ISTHEarlyCareer Sarah Sewaralthahab, MD, MPH, ABIM Shrey Kohli Becky Zon, MD Aaron Iding Nicola Potere

A recent Swedish nationwide study reveals that venous thromboembolism (VTE) is linked with a small but notable percentage of out-of-hospital cardiac arrests (OHCA), particularly affecting younger women. The research emphasizes the critical need for improved preventive measures

Honored, thrilled, thankful for the opportunity — 🔥#thromboinflammation (NLRP3/IL-1) & #VTE 🩸— such an exciting field harbouring transformative discoveries and soon therapeutic advances🌟 🎥 soon available at: canvector.ca Thank you CanVECTOR Network Joseph R. Shaw ++

Did you know? Around 50% of patients with acute CAT in your practice do not meet the inclusion criteria of the RCTs. Listen to the podcast with Geoff Barnes about recent trials taking a more pragmatic approach. Medthority medthority.com/medical-educat…

Attention all @ISTH members located in North America! This is your opportunity to shape the field of #thrombosis and #hemostasis: Apply now for the position of 2027 Annual Congress Planning Committee Chair. Deadline is March 14. To learn more and apply see link 👇

Attention all @ISTH members! This is your opportunity to shape the future of the ISTH and the field of #thrombosis and #hemostasis by serving as a volunteer on an ISTH committee! Deadline for applications is March 3! To learn more and apply see 👇

Interested in the fundamentals of key topics in #thrombosis and #hemoastasis? Don't miss the BRAND NEW Educational Review Series in ISTH JTH Check it out 👇

As we prepare for the #ISTH2025 Congress in Washington, D.C., we are reminded of the strength of our global community. The ISTH remains firmly dedicated to advancing science, supporting research and fostering innovation across borders. Read more: isth.org/news/695029/Me…

Exited to share our paper on biological aging in #hemophilia, an inherited bleeding disorder with significant improvements in life expectancy over the last decades. Our results indicate an accelerated biological aging in people with hemophilia. ➡️ doi.org/10.3324/haemat…

🥳 Thrilled to share our new study about post-thrombotic vascular sequelae 💡After PE, low CD34⁺ cell levels at RPVO assessment suggest a decreased regenerative potential contributing to perfusion defects INNOVTE ⤵️

Post-hoc analysis of the Hokusai VTE Cancer trial showed that treatment for recurrent VTE on AC were heterogeneous, and there were high risks of second recurrent VTE (9%) and major bleeding (10%) within 3 months! doi.org/10.1016/j.jtha… JTH Gary Raskob Marc Carrier

👥 Meet the future of thrombosis and hemostasis research. In "Leading from the Start", we highlight the pivotal role of the ISTH SSC and its Early Career Co-Chairs—emerging leaders who are already making a global impact. Read more here: bit.ly/3XOmNCI

So inspiring to see the #ISTHearlycareer leaders play important roles to advance many ISTH program. Learn more about ISTH #SSC Co-Chairs and their important contributions: ➡️Gael Morrow ➡️Dino Mehic ➡️Aaron Iding ➡️Cheryl Maier

🌍 Big ideas start early. Leadership does too. The ISTH SSC is where innovation meets mentorship—and Early Career Co-Chairs are at the heart of it. In our latest article, we spotlight four rising leaders who are already shaping the future of the field: bit.ly/3XOmNCI

📢 Practice-changing data from the Adjust-DVT study! ✅ Age-adjusted D-dimer safely rules out DVT in low/non-high pretest probability patients 📉 Reduces unnecessary ultrasounds 🔍 +17% yield in patients ≥75 years #ISTH2025 #DVT #Thrombosis #LessIsMore